Literature DB >> 12172735

Effects of methylprednisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury.

Cahide Topsakal1, Fatih S Erol, M Faik Ozveren, Nejat Yilmaz, Nevin Ilhan.   

Abstract

OBJECTIVE: This study examines the effects of agents purported to improve recovery following spinal cord trauma, methylprednisolone sodium succinate, dextromethorphan, and the combination of both, on the post-traumatic alterations of membrane lipid metabolism.
METHODS: After sparing ten rats for a control group (G1) and performing T3-T6 laminectomies in 150 rats, spinal cord injuries were accomplished in 120 of 150 Wistar rats with an aneurysmal clip compression at the level of T4-5 for 30 sec. Hence the G2 group ( n 30) included the "only laminectomy/sham" group. The 120 injured animals were subdivided into four equal groups ( n 30 each). Group G3 underwent no therapy, G4 methylprednisolone (MP), G5 dextromethorphan (DM), and G6 MP+DM therapies. Groups G2-G6 were killed ten by ten at 10 min, 30 min, and 120 min after the operation. We measured tissue (MDA) and blood malonyldialdehyde (MDAb), (a product of lipid peroxidation) levels as an indicator of oxidative damage by thiobarbituric acid method and activity levels of antioxidant enzymes superoxide dismutase and glutathione peroxidase in erythrocytes. Intergroup and intragroup results were compared statistically.
RESULTS: Methylprednisolone was able to keep the levels for all parameters close to baseline except for 30-min MDA, MDA(b), and SOD values. But their results were all different from those of G3. Dextromethorphan was successful in this respect at 30-min GSH-Px and 120-min SOD and GSH-Px, and all values were also different from G3 values except for 10-min MDA, SOD, and GSH-Px. Combined therapy was not able to keep levels close to baseline for all parameters, but they were different from G3's except for the GSH-Px values. Methylprednisolone values displayed minimal alterations according to baseline at 120 min. Dextromethorphan was relatively unsuccessful at 10 min. Combined therapy did not show benefit superior to MP/DM single therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12172735     DOI: 10.1007/s101430100183

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  8 in total

1.  Protective effect of beta-glucan on contrast induced-nephropathy and a comparison of beta-glucan with nebivolol and N-acetylcysteine in rats.

Authors:  Eyup Koc; Kadriye Altok Reis; Fatma Ayerden Ebinc; Hatice Pasaoglu; Canan Demirtas; Suna Omeroglu; Ulver Boztepe Derici; Galip Guz; Yasemin Erten; Musa Bali; Turgay Arinsoy; Sukru Sindel
Journal:  Clin Exp Nephrol       Date:  2011-04-26       Impact factor: 2.801

2.  Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.

Authors:  Olga V Chechneva; Florian Mayrhofer; Daniel J Daugherty; David E Pleasure; Jau-Shyong Hong; Wenbin Deng
Journal:  Neurobiol Dis       Date:  2011-06-24       Impact factor: 5.996

3.  The antioxidant effect of beta-Glucan on oxidative stress status in experimental spinal cord injury in rats.

Authors:  Hakan Kayali; M Fatih Ozdag; Serdar Kahraman; Ahmet Aydin; Engin Gonul; Ahmet Sayal; Zeki Odabasi; Erdener Timurkaynak
Journal:  Neurosurg Rev       Date:  2005-04-30       Impact factor: 3.042

4.  Preparation and activity analysis of recombinant human high-density lipoprotein.

Authors:  Manman Su; Weiqin Chang; Kaiyao Shi; Dingding Wang; Mingxing Wang; Tianmin Xu; Weiqun Yan
Journal:  Assay Drug Dev Technol       Date:  2012-08-16       Impact factor: 1.738

Review 5.  Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury.

Authors:  Young-tae Kim; Jon-Michael Caldwell; Ravi V Bellamkonda
Journal:  Biomaterials       Date:  2009-01-30       Impact factor: 12.479

6.  Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan.

Authors:  Xiaofeng Xu; Bin Zhang; Kaili Lu; Jiangshan Deng; Fei Zhao; Bing-Qiao Zhao; Yuwu Zhao
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

7.  Mn (III) tetrakis (4-benzoic acid) porphyrin scavenges reactive species, reduces oxidative stress, and improves functional recovery after experimental spinal cord injury in rats: comparison with methylprednisolone.

Authors:  Danxia Liu; Yichu Shan; Lokanatha Valluru; Feng Bao
Journal:  BMC Neurosci       Date:  2013-03-01       Impact factor: 3.288

8.  Neuroprotective effect of combining tanshinone IIA with low-dose methylprednisolone following acute spinal cord injury in rats.

Authors:  Nian-Wei Yao; Yuan Lu; Li-Qi Shi; Feng Xu; Xian-Hua Cai
Journal:  Exp Ther Med       Date:  2017-03-28       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.